Vimarsana
Biggest News Aggregation in the World

Page 19 - Cingulate Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cingulate Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cingulate Inc Today - Breaking & Trending Today

Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event - Vimarsana News

Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Cingulate and ADHD Expert Dr. Ann Childress, MD to - Vimarsana News

Cingulate and ADHD Expert Dr. Ann Childress, MD to

KANSAS CITY, Kan., June 02, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary...

Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event - Vimarsana News

Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event

02.06.2022 - KANSAS CITY, Kan., June 02, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology to build and advance a pipeline ...

Cingulate Announces Complete Enrollment in Human Formulation Study of CTx-2103 for the Treatment of Anxiety Disorders - Vimarsana News

Cingulate Announces Complete Enrollment in Human Formulation Study of CTx-2103 for the Treatment of Anxiety Disorders

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Cingulate Inc. Reports First Quarter 2022 Results and Provides Clinical and Business Update - Vimarsana News

Cingulate Inc. Reports First Quarter 2022 Results and Provides Clinical and Business Update

Announcement of First Dosage for Anxiety Candidate CTx-2103 to Extend the Application of the Precision Timed Release™ Platform KANSAS CITY, Kan., May 12, 2022 -- Cingulate Inc. , a... | May 12, 2022